ProShare Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Sell |
25,105
-2,486
| -9% | -$12.5K | ﹤0.01% | 1824 |
|
|
2025
Q1 | $179K | Sell |
27,591
-5,972
| -18% | -$38.7K | ﹤0.01% | 1721 |
|
|
2024
Q4 | $246K | Buy |
33,563
+6,767
| +25% | +$49.7K | ﹤0.01% | 1768 |
|
|
2024
Q3 | $201K | Buy |
26,796
+5,441
| +25% | +$40.8K | ﹤0.01% | 1730 |
|
|
2024
Q2 | $190K | Sell |
21,355
-5,037
| -19% | -$44.8K | ﹤0.01% | 1540 |
|
|
2024
Q1 | $267K | Buy |
26,392
+2,035
| +8% | +$20.6K | ﹤0.01% | 1501 |
|
|
2023
Q4 | $245K | Buy |
24,357
+2,789
| +13% | +$28.1K | ﹤0.01% | 1522 |
|
|
2023
Q3 | $202K | Buy |
21,568
+13
| +0.1% | +$122 | ﹤0.01% | 1458 |
|
|
2023
Q2 | $529K | Buy |
21,555
+1,693
| +9% | +$41.5K | ﹤0.01% | 921 |
|
|
2023
Q1 | $462K | Sell |
19,862
-3,841
| -16% | -$89.4K | ﹤0.01% | 947 |
|
|
2022
Q4 | $600K | Buy |
23,703
+1,288
| +6% | +$32.6K | ﹤0.01% | 879 |
|
|
2022
Q3 | $431K | Buy |
22,415
+619
| +3% | +$11.9K | ﹤0.01% | 965 |
|
|
2022
Q2 | $556K | Sell |
21,796
-4,843
| -18% | -$124K | ﹤0.01% | 905 |
|
|
2022
Q1 | $685K | Sell |
26,639
-6,759
| -20% | -$174K | ﹤0.01% | 1097 |
|
|
2021
Q4 | $1.4M | Sell |
33,398
-3,941
| -11% | -$165K | ﹤0.01% | 879 |
|
|
2021
Q3 | $1.63M | Sell |
37,339
-4,018
| -10% | -$175K | ﹤0.01% | 764 |
|
|
2021
Q2 | $1.96M | Buy |
41,357
+8,126
| +24% | +$384K | 0.01% | 730 |
|
|
2021
Q1 | $1.7M | Buy |
33,231
+536
| +2% | +$27.5K | 0.01% | 753 |
|
|
2020
Q4 | $876K | Buy |
32,695
+25,010
| +325% | +$670K | ﹤0.01% | 945 |
|
|
2020
Q3 | $264K | Buy |
7,685
+1,259
| +20% | +$43.3K | ﹤0.01% | 1264 |
|
|
2020
Q2 | $263K | Buy |
+6,426
| New | +$263K | ﹤0.01% | 1300 |
|